2014 Patient Satisfaction Survey

Results from the 2014 Patient Satisfaction Survey are in and the IHTC earned high marks once again! 96.9% of patients rated the IHTC’s overall quality of care as good to excellent. Thanks to everyone for providing the highest level of patient care! Read a summary of results here.

Hemaware Magazine recently featured the Partner’s in Bleeding Disorders program

The National Hemophilia Foundation’s monthly patient-oriented bleeding disorder magazine, “Hemaware” featured an article about the Partner’s in Bleeding Disorders program. The article features several quotes from Natalie and Dr. Shapiro and described the indirect benefits of the Partners Program to patients by increasing the competency of their providers. Check it out here.

IHTC has Moved!

As of September 8, the IHTC has a new home and address: 8326 Naab Rd, Indianapolis, IN 46260. For more information about our new home, visit

Biogen Idec’s ELOCTATE™ is now approved by the FDA for hemophilia A (factor VIII deficiency).

The US Food and Drug Administration (FDA) has approved Biogen Idec’s ELOCTATE™ for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with hemophilia A (factor VIII deficiency). Visit the National Hemophilia Foundation’s website for more details.

First long-acting factor IX concentrate approved for patients with hemophilia B!

The U.S. Food and Drug Administration has approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have hemophilia B.

CHC & Healthcare Reform

IHTC Community Programs Director Chris Roberson and Amish Community Leader Dennis Lehman were interviewed by NPR last week for a story aired on Weekend Edition.

Living our Mission

The IHTC is pleased announce the release of Living Our Mission. You are invited to read how the IHTC’s efforts, programs and services support the center’s mission to care for patients and their families.

My Story of Hepatitis C & Treatment

Mark* is an IHTC patient with hepatitis C. Hepatitis C is a viral infection that causes liver disease. Mark also has HIV, contracted many years ago from non-virally inactivated plasma-derived clotting factor concentrates. We asked Mark to share his story of living with and seeking treatment for hepatitis C. When were you diagnosed with hepatitis […]

Patient Experience Surveys

The IHTC has partnered with Professional Research Consultants, Inc. (PRC) of Omaha, Nebraska to conduct Patient Experience Surveys.

Visit the newly launched website of the Community Health Clinic (CHC)

Visit the newly launched website of the Community Health Clinic (CHC), a nonprofit healthcare facility serving the Amish, Mennonite, and rural northeastern Indiana communities.

« Previous PageNext Page »